Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...
TMCnet

Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board

Globally recognized leader in early-phase oncology clinical development and experimental therapeutics. Strengthens strategic ...

Akari Therapeutics Plc: Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific …

Globally recognized leader in early-phase oncology clinical development and experimental therapeutics Strengthens strategic ...
GitHub

Xnhyacinth/Awesome-LLM-Long-Context-Modeling

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...